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Abstract
Background: Public proteomics databases such as PeptideAtlas contain peptides and proteins identified in mass
spectrometry experiments. However, these databases lack information about human disease for researchers
studying disease-related proteins. We have developed mspecLINE, a tool that combines knowledge about human
disease in MEDLINE with empirical data about the detectable human proteome in PeptideAtlas. mspecLINE
associates diseases with proteins by calculating the semantic distance between annotated terms from a controlled
biomedical vocabulary. We used an established semantic distance measure that is based on the co-occurrence of
disease and protein terms in the MEDLINE bibliographic database.
Results: The mspecLINE web application allows researchers to explore relationships between human diseases and
parts of the proteome that are detectable using a mass spectrometer. Given a disease, the tool will display proteins
and peptides from PeptideAtlas that may be associated with the disease. It will also display relevant literature from
MEDLINE. Furthermore, mspecLINE allows researchers to select proteotypic peptides for specific protein targets in a
mass spectrometry assay.
Conclusions: Although mspecLINE applies an information retrieval technique to the MEDLINE database, it is
distinct from previous MEDLINE query tools in that it combines the knowledge expressed in scientific literature
with empirical proteomics data. The tool provides valuable information about candidate protein targets to
researchers studying human disease and is freely available on a public web server.
Background
Public databases of mass spectrometry experiments con-
tain an enormous amount of data about the human pro-
teome. Repositories such as PeptideAtlas [1], PRIDE [2],
and Peptidome [3] contain peptides and proteins identi-
fied in experiments as well as the empirical evidence to
support such identifications. These databases are essen-
tial resources for planning mass spectrometry assays,
especially in a targeted proteomics workflow where
researchers must identify proteotypic peptides for a tar-
get protein based on the results of previous experiments
[4]. Proteotypic peptides are those peptides that most
strongly indicate the presence of a target protein in a
sample. They are known to be observable in a mass
spectrometer and they map to a unique location in the
human genome [5].
Mass spectrometry has significant potential in study-
ing proteins that are involved in human disease. For
example, researchers have identified virulence factors of
Streptococcus pyogenes bacteria [6], candidate biomar-
kers for erosive rheumatoid arthritis [7], and candidate
plasma biomarkers for ovarian cancer [8] using mass
spectrometry. Targeted mass spectrometry approaches
(e.g., multiple reaction monitoring) can now detect and
quantify proteins of very low abundance relative to
traditional shotgun approaches (e.g., tandem mass spec-
trometry) [9], allowing researchers to identify disease-
related protein targets with high sensitivity.
Unfortunately, mass spectrometry experiment
databases do not currently support searching for dis-
ease-related proteins and peptides. Although further
integration with genomic databases as in PeptideAtlas
[10] could allow researchers to search for proteins as
products of a disease-related gene, this would require
knowledge of a specific gene that is implicated in a dis-
ease. Ideally, proteomics databases should be integrated
with knowledge bases of human disease such that
researchers may search for candidate protein targets for * Correspondence: jboyle@systemsbiology.org
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mspecLINE, a tool to assist researchers in exploring the
detectable human proteome for disease-related proteins.
Using terms from a controlled biomedical vocabulary,
mspecLINE associates diseases with sets of proteins by
finding the semantic distances between them in pre-
viously published scientific literature. mspecLINE allows
researchers to enter a disease and view all proteins asso-
ciated with that disease in the MEDLINE bibliographic
database. It also aids researchers in developing targeted
assays for disease-related proteins by displaying proteins
and peptides from PeptideAtlas that are detectable using
the current generation of mass spectrometry
instruments.
By combining knowledge about disease with empirical
data about the proteome, mspecLINE offers a unique
new interface to assist proteomics researchers who are
studying proteins that are involved in human disease.
We provide an overview of the data sources used by
mspecLINE and discuss relevant work on biomedical
information retrieval below.
Data sources overview
mspecLINE incorporates data from a number of sources
including the Medical Subject Headings vocabulary,
MEDLINE, and PeptideAtlas.
mspecLINE uses the Medical Subject Headings
(MeSH) vocabulary to identify semantic relationships
between diseases and proteins. MeSH is a controlled
vocabulary of biomedical descriptors arranged in a hier-
archical structure that can be modeled as a set of trees
[11]. MeSH descriptors are assigned to nodes in a parti-
cular tree by their subject category. For example, the
disease descriptor ‘Prostatic Neoplasms’ is assigned to a
node in the ‘Diseases’ tree while the enzyme descriptor
‘Acid Phosphatase’ is assigned to a node in the ‘Chemi-
cals & Drugs’ tree.
Each reference in the MEDLINE bibliographic data-
base [12] is manually curated and annotated with rele-
vant descriptors from the MeSH vocabulary. For
example, an article on Parkinson Disease might be
annotated with the MeSH descriptors ‘Parkinson Dis-
ease’ and ‘alpha-Synuclein’. mspecLINE analyzes these
annotations to associate diseases with proteins. MED-
LINE represents an enormous collection of biomedical
knowledge about human disease and it currently con-
tains references to more than 16 million articles.
Additionally, mspecLINE uses data from PeptideAtlas,
a publicly accessible repository that currently contains
empirical data pertaining to more than 130,000 human
peptides identified in mass spectrometry experiments.
The database also maps peptides to their parent proteins
and to their locations in the human genome [10]. Pro-
teins in PeptideAtlas are uniquely identified by accession
numbers that can be easily mapped to identifiers used in
other protein databases. PeptideAtlas contains high
quality data and represents the state of the art in
empirical proteomics databases.
Information retrieval techniques
Investigators have applied numerous information retrie-
val techniques to extract relationships from biomedical
knowledge bases. Many of these techniques involve
semantic analysis using Latent Semantic Indexing (LSI)
[13]. For example, Homayouni et al. [14] successfully
used LSI to cluster genes by extracting conceptual rela-
tionships from MEDLINE abstracts. Furthermore, Khatri
et al. used LSI to identify novel gene function annota-
tions by analyzing previous annotations in the human
genome [15].
Other investigators have applied co-occurrence analy-
sis techniques to extract relationships from biomedical
literature. The Associative Concept Space method, for
instance, extracts associations between concepts in lit-
erature using co-occurrence data as input [16]. Addi-
tionally, Stapley et al. developed a method for extracting
gene-function relationships from MEDLINE using co-
occurrence data [17]. Others have extracted gene and
protein synonyms [18] as well as gene clusters [19] from
MEDLINE using co-occurrence analysis.
mspecLINE associates diseases with proteins by calcu-
lating the semantic distance between MeSH annotations
in MEDLINE using Normalized Google Distance
(NGD). NGD is grounded in the well-established theory
of Kolmogorov complexity [20] and the Normalized
Information Distance (NID) between two objects [21].
NID is a general purpose distance measure that is inti-
mately related to coding and compression and it has
been successful in a number of contexts including geno-
mics-based phylogeny [22], music clustering [23], and a
variety of other applications [24-26]. NGD can be
applied to measure the semantic distance between
objects in any set of documents. Cilibrasi and Vitányi
showed that NGD is effective in distinguishing concepts
such as colors and numbers, names of paintings by
17th-century Dutch masters, books by English novelists,
and in performing automatic English-Spanish transla-
tion. Furthermore, they demonstrated that NGD can be
used in a supervised learning setting to accurately clas-
sify words into categories in the WordNet database.
NGD is similar to LSI in that it can be used to calculate
semantic distance between objects, however it is much
more computationally feasible than LSI when working
with very large document sets such as MEDLINE and it
does not require any parameter tuning [27].
NGD is defined as a value between 0 and 1 that indi-
cates the semantic distance between two terms in a set
of documents. It uses the co-occurrence of two terms in
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two terms occur frequently in the same documents,
those terms are said to be highly related and have a low
NGD value. Likewise, if two terms rarely occur in the
same documents, those terms are said to be unrelated
and have a high NGD value. We apply the NGD mea-
sure to the MEDLINE database, so we shall refer to it as
Normalized MEDLINE Distance (NMD) throughout this
paper. We describe our calculation of NMD in detail in
the following section.
Implementation
mspecLINE builds sets of MeSH disease descriptors and
MeSH protein descriptors, then calculates the semantic
distances between each pair of descriptors using NMD.
We describe our method and provide an overview of
the tool’s architecture below.
Building MeSH descriptor sets
First, we used the 2009 MeSH distribution from the
National Library of Medicine (NLM) to find all descrip-
tors in the ‘Diseases’ tree. In total, our set of diseases D
consisted of 4,323 MeSH descriptors.
We then extracted a list of all unique protein acces-
sions in PeptideAtlas. We used BioThesaurus [28] to
find Unified Medical Language System (UMLS) [29]
concept annotations for each protein. UMLS is a biome-
dical vocabulary that is distinct from MeSH. Proteins in
BioThesaurus are annotated with UMLS concepts by
matching the protein name in public protein databases
to a UMLS concept name. Although BioThesaurus pro-
vides UMLS concept annotations derived from partial
matches to the protein name, we only used annotations
that were derived from an exact match. The MeSH dis-
tribution from NLM provides a mapping from UMLS
concepts to MeSH concepts and using this UMLS-
MeSH concept map, we annotated each PeptideAtlas
protein with MeSH descriptors that are equivalent to
the UMLS concepts in BioThesaurus. We filtered out
any MeSH descriptors not in the ‘Chemicals & Drugs’
tree as we are specifically concerned with those relevant
to proteins. Finally, we constructed a set P containing
2,585 MeSH protein descriptors to represent all unique
annotations for proteins in PeptideAtlas.
Associating diseases with proteins
To associate the diseases described in MeSH with the
proteins in PeptideAtlas, we calculated pairwise seman-
tic distances between each MeSH disease descriptor in
D and each MeSH protein descriptor in P by analyzing
article annotations in MEDLINE. We ran our calcula-
tions using a local copy of the 2008 MEDLINE database
on lease from NLM. For each MeSH disease descriptor
d Î D and each MeSH protein descriptor p Î P, we cal-
culated NMD(d, p) as:
NMD d p
gmax dp fdp
Mg min dp
(,)
(,)l o g(,)
log ( , )
. 


We define f (d, p) as the number of articles in MED-
LINE that are annotated with both d and p,a n dM as
the total number of articles in MEDLINE. Further, we
define gmax(d, p) and gmin(d, p) as:
gd p f d f p
gd p f d f
max
min
( , ) max{log ( ),log ( )},
( , ) min{log ( ),log (

 p p)}.
We define f (d) as the number of articles in MEDLINE
that are annotated with d,a n df (p)a st h en u m b e ro f
articles that are annotated with p.
A ss h o w ni nF i g u r e1 ,e a c hp a i r w i s eN M Dv a l u e
associates a MeSH disease descriptor with a MeSH pro-
tein descriptor. Together, these associations allow us to
find proteins and peptides from PeptideAtlas that may
be related to a specific disease.
Architecture
Our software consists of four main components: the
N M DD a t aS t o r e ,t h eM E D L I N ED a t aS t o r e ,t h em s p e -
cLINE Data Service, and the mspecLINE web user inter-
face (UI). Figure 2 shows a high-level view of
mspecLINE and its data inputs.
The NMD Data Store has a denormalized schema that
encodes the associations depicted in Figure 1. It stores
MeSH descriptor pairs along with their NMD values,
PeptideAtlas protein identifiers, and PeptideAtlas pep-
tide identifiers. The MEDLINE Data Store contains
MeSH descriptor pairs along with PubMed identifiers
for articles that are annotated with both descriptors in a
pair. The mspecLINE Data Service aggregates data from
downstream sources and provides it to the UI via a web
service. The Data Service obtains additional protein and
peptide information from the PeptideAtlas caGrid
service.
PeptideAtlas caGrid Service
We developed a web service on top of PeptideAtlas that
operates on the Cancer Biomedical Informatics Grid
with caGrid infrastructure [30]. The PeptideAtlas caGrid
Service enables clients li k em s p e c L I N Eb yp r o v i d i n g
them with detailed information about proteins and pep-
tides in PeptideAtlas. The service has a well-defined
query interface that is integrated with the Cancer Com-
mon Ontologic Representation Environment (caCORE)
[31]. Query-able objects in the PeptideAtlas caGrid Ser-
vice are annotated with metadata and terms from the
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interoperability with other caGrid services and provides
clients such as mspecLINE with detailed semantic infor-
mation about objects in the service interface.
Results
Researchers interact with mspecLINE by entering a dis-
ease in the UI and viewing associated proteins, peptides,
and MEDLINE literature. We provide a walkthrough
below using Creuztfeldt-Jakob Syndrome as an example
disease. Figure 3 shows a screen capture of the mspe-
cLINE UI and we will refer to it throughout this
example.
Finding disease-related proteins
First, the researcher enters a proper MeSH descriptor
name for a disease. He may click on a link to open the
NLM MeSH browser and find the proper name. In our
example, the MeSH disease name is ‘Creutzfeldt-Jakob
Syndrome’ and mspecLINE finds all matching entries in
the NMD Data Store. The UI displays MeSH protein
descriptors that are semantically related to Creutzfeldt-
Jakob Syndrome in the left panel along with their NMD
values: Prions (0.17), 14-3-3 Proteins (0.35), and PrPC
Proteins (0.36). The researcher may select or de-select
MeSH protein descriptors in the left panel and the
other views will filter and update accordingly. It is
important to note that mspecLINE only retrieves seman-
tically related protein descriptors below a threshold
NMD value. In our example, we have chosen an arbi-
trary NMD threshold of 0.5, although the UI allows
researchers to adjust the threshold.
mspecLINE displays all proteins annotated with one or
more of the MeSH protein descriptors in the center
panel. The center panel also lists peptides from Pepti-
deAtlas for each protein, the amino acid sequence for
Figure 1 The associations between diseases, proteins, and peptides in mspecLINE.F i r s t ,w ec o n s t r u c t e ds e t so fa l lM e S Hd i s e a s e
descriptors and all unique MeSH protein descriptors for proteins in PeptideAtlas. Next, we associated diseases with proteins by calculating
pairwise NMD values between disease and protein descriptors. Last, we incorporated protein-peptide mappings from PeptideAtlas to construct
lists of possible disease-related peptides that are observable in a mass spectrometer.
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each protein. In our example, mspecLINE found a total
of 305 peptides from PeptideAtlas for proteins that may
be related to Creutzfeldt-Jakob Syndrome.
The center panel allows the researcher to sort and
group peptides by different fields. For example, she may
want to find all peptides detectable for a specific target
protein related to Creutzfeldt-Jakob Syndrome, therefore
she groups peptides by the ‘Protein’ field.
Selecting proteotypic peptides
As previously discussed, selecting proteotypic peptides
for a protein is an essential step in developing a targeted
mass spectrometry assay. mspecLINE displays the Pepti-
deAtlas Empirical Observability Score (EOS) for each
peptide in the center panel, which indicates the empiri-
cal likelihood that a researcher would observe a specific
peptide if its parent protein is detected in the sample
[4]. mspecLINE also indicates whether each peptide has
a unique mapping in the human genome. The
researcher can use this information to select proteotypic
peptides for a specific protein target. For example, if he
is interested in targeting [IPI:IPI00759832], a protein
annotated with the MeSH descriptor ‘14-3-3 Proteins’,
he should select peptides with high EOS scores and
unique genome mappings such as [PeptideAltas:
PAp00032686]. The researcher may export a list of
selected peptides from mspecLINE as a tab-separated
values file.
Viewing protein and peptide details
The center panel in the mspecLINE UI displays only
minimal information about disease-related proteins and
peptides. The researcher may click in the table to open
a protein details tab that contains additional information
about a protein and its peptides from PeptideAtlas. The
information in the tab includes the name of the gene
that encodes the protein and a detailed description of
the protein. The tab also provides additional empirical
information about the protein’s peptides including the
isoelectric point, molecular mass, and hydrophobicity of
each peptide.
Browsing MEDLINE references
mspecLINE displays all MEDLINE references that con-
tribute to the association of a disease with a set of pro-
teins in the lower panel. The UI queries the MEDLINE
Data Store to find all article references that are anno-
tated with both the input MeSH disease descriptor and
one or more of the associated MeSH protein descrip-
tors. In our example, mspecLINE found 118 articles in
the MEDLINE database that are annotated with the
MeSH descriptors ‘Creutzfeldt-Jakob Syndrome’ and ‘14-
3-3 Proteins’. The researcher can use the MEDLINE
Figure 2 The high-level architecture of mspecLINE. Using custom Ruby scripts, we extracted data from BioThesaurus, MEDLINE, and MeSH to
construct the NMD and MEDLINE Data Stores in a MySQL database. The mspecLINE Data Service collates protein and peptide information from
the PeptideAtlas caGrid Service along with data from the Data Stores. We implemented the Data Service in Java and it presents data to the
Javascript-based mspecLINE Web User Interface via a web service. The web service could be used by other applications to access mspecLINE
data.
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related proteins. She may also click on a specific refer-
ence and open the PubMed article entry in a separate
browser window. In our example, the MEDLINE refer-
ences include numerous articles discussing the 14-3-3
brain protein as a clinical marker for Creutzfeldt-Jakob
Syndrome in cerebrospinal fluid.
Visualizing associations
In addition to the tabular view in the center panel of the
UI, mspecLINE provides a visualization of associations
between a disease, MeSH protein descriptors, as well as
proteins and peptides from PeptideAtlas. The researcher
can click the ‘Visualize’ button to visualize these associa-
tions in a network using Cytoscape [32]. The visualiza-
tion allows researchers to easily identify relationships
between disease-related proteins and peptides from Pep-
tideAtlas. For example, researchers can distinguish pep-
tides that are unique to a specific disease-related protein
versus those that may identify multiple disease-related
proteins in a mass spectrometry experiment. Figure 4
shows part of the mspecLINE visualization for Creutz-
feldt-Jakob Syndrome.
Discussion
Investigators have developed numerous tools for query-
ing MEDLINE. For example, GoPubMed allows
researchers to query and browse MEDLINE using terms
f r o mt h eG e n eO n t o l o g y[ 3 3 ] .O t h e rt o o l ss u c ha s
FACTA [34] show semantic relationships in a MED-
LINE query result set. Although mspecLINE is similar
to these tools in that it applies an information retrieval
Figure 3 Screen capture of the mspecLINE web user interface showing Creutzfeldt-Jakob Syndrome as an example disease. Researchers
may review possible disease-related proteins and peptides observable in mass spectrometry experiments, review relevant literature from
MEDLINE, and export selected peptides for later use.
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MEDLINE query tool.
mspecLINE is unique in that it combines knowledge
about human disease from MEDLINE with empirical
data about the detectable human proteome from Pepti-
deAtlas. It is intended for researchers who study speci-
fic diseases and wish to explore candidate proteins for
targeting in mass spectrometry experiments. For exam-
ple, researchers seeking proteins that may be markers
for disease could use mspecLINE to identify candidate
protein targets and proteotypic peptides for those tar-
gets. They could subsequently use analytical tools such
as Corra [35] to identify differentially expressed targets
among diseased versus non-diseased sample groups.
Researchers could also use mspecLINE to browse
recent biomedical literature regarding disease-related
proteins.
We have identified a number of future enhancements
for mspecLINE. First, we are exploring procedures to
empirically validate our method for associating diseases
with proteins. Second, we are investigating techniques
to automatically determine an appropriate threshold for
Normalized MEDLINE Distance when a researcher
enters a MeSH disease descriptor. Last, we are research-
ing data management systems that would allow us to
more effectively store and process the data that we use
in our method. Specifically, we are looking at integrating
mspecLINE with the Addama infrastructure [36] and
developing an automated pipeline to update our Data
Stores whenever a new release of MEDLINE is available.
Conclusions
Mass spectrometry is a promising technology to study
proteins involved in human disease. We have presented
mspecLINE, a new tool that bridges empirical proteo-
mics data with knowledge about human disease. As we
have demonstrated using an example disease, mspe-
cLINE allows researchers to explore potential disease-
related protein targets based on semantic distances
between disease and protein annotations in MEDLINE.
The tool also assists researchers in identifying proteoty-
pic peptides for mass spectrometry assays. mspecLINE
is open source software and is freely available for use on
a public web server.
Figure 4 A portion of the mspecLINE network visualization for Creutzfeldt-Jakob Syndrome. The visualization allows researchers to see
relationships between disease-related proteins and peptides from PeptideAtlas.
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Page 7 of 9Availability and requirements
￿ Project name: mspecLINE
￿ Project home page: http://informatics.systemsbiol-
ogy.net/informatics/mspecLINE
￿ Operating system(s): Platform independent
￿ Programming languages: Ruby, Java, Javascript
￿ License: Apache License, Version 2.0
Acknowledgements
This work was supported by grant number 1R011CA1374422 from the
National Cancer Institute. The content is solely the responsibility of the
authors and does not necessarily represent the official views of the National
Institutes of Health.
Authors’ contributions
JH developed the mspecLINE software, the PeptideAtlas caGrid service,
performed data collection and analysis, and drafted the manuscript. ED
participated in development of the PeptideAtlas caGrid service. JB initiated
and guided the investigation, conceived the application of Normalized
Google Distance in our method, and participated in designing the user
interface. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 23 October 2009 Accepted: 10 March 2010
Published: 10 March 2010
References
1. Desiere F, Deutsch EW, King NL, Nesvizhskii AI, Mallick P, Eng J, Chen S,
Eddes J, Loevenich SN, Aebersold R: The PeptideAtlas project. Nucleic Acids
Research 2006, , 34 Database: 655-658.
2. Jones P, Cote RG, Martens L, Quinn AF, Taylor CF, Derache W, Hermjakob H,
Apweiler R: PRIDE: a public repository of protein and peptide
identifications for the proteomics community. Nucleic Acids Research 2006,
, 34 Database: 659-663.
3. Slotta DJ, Barrett T, Edgar R: NCBI Peptidome: a new public repository for
mass spectrometry peptide identifications. Nature Biotechnology 2009,
27(7):600-601.
4. Deutsch EW, Lam H, Aebersold R: PeptideAtlas: a resource for target
selection for emerging targeted proteomics workflows. EMBO Reports
2008, 9(5):429-434.
5. Mallick P, Schirle M, Chen SS, Flory MR, Lee H, Martin D, Ranish J, Raught B,
Schmitt R, Werner T, Kuster B, Aebersold R: Computational prediction of
proteotypic peptides for quantitative proteomics. Nature Biotechnology
2007, 25:125-131.
6. Lange V, Malmström JA, Didion J, King NL, Johansson BP, Schäfer J,
Rameseder J, Wong CH, Deutsch EW, Brusniak MY, Bühlmann P, Björck L,
Domon B, Aebersold R: Targeted quantitative analysis of Streptococcus
pyogenes virulence factors by multiple reaction monitoring. Molecular &
Cellular Proteomics 2008, 7(8):1489-1500.
7. Liao H, Wu J, Kuhn E, Chin W, Chang B, Jones M, O’Neil S, Clauser K, Karl J,
Hasler F, Roubenoff R, Zolg W, Guild B: Use of mass spectrometry to
identify protein biomarkers of disease severity in the synovial fluid and
serum of patients with rheumatoid arthritis. Arthritis & Rheumatism 2004,
50(12):3792-3803.
8. Ye B, Cramer DW, Skates SJ, Gygi SP, Pratomo V, Fu L, Horick NK,
Licklider LJ, Schorge JO, Berkowitz RS, Mok SC: Haptoglobin-alpha subunit
as potential serum biomarker in ovarian cancer: identification and
characterization using proteomic profiling and mass spectrometry.
Clinical Cancer Research 2003, 9(8):2904-2911.
9. Picotti P, Bodenmiller B, Mueller LN, Domon B, Aebersold R: Full Dynamic
Range Proteome Analysis of S. cerevisiae by Targeted Proteomics. Cell
2009, 138(4):795-806.
10. Desiere F, Deutsch EW, Nesvizhskii AI, Mallick P, King NL, Eng JK, Aderem A,
Boyle R, Brunner E, Donohoe S, Fausto N, Hafen E, Hood L, Katze MG,
Kennedy KA, Kregenow F, Lee H, Lin B, Martin D, Ranish JA, Rawlings DJ,
Samelson LE, Shiio Y, Watts JD, Wollscheid B, Wright ME, Yan W, Yang L,
Yi EC, Zhang H, Aebersold R: Integration with the human genome of
peptide sequences obtained by high-throughput mass spectrometry.
Genome Biology 2005, 6.
11. Lowe HJ, Barnett GO: Understanding and Using the Medical Subject
Headings (MeSH) Vocabulary to Perform Literature Searches. Journal of
the American Medical Association 1994, 271(14):1103-1108.
12. MEDLINE Fact Sheet. 2008 [http://www.nlm.nih.gov/pubs/factsheets/
medline.html].
13. Deerwester S, Dumais ST, Furnas GW, Landauer TK, Harshman R: Indexing
by Latent Semantic Analysis. Journal of the American Society for
Information Science 1990, 41:391-407.
14. Homayouni R, Heinrich K, Wei L, Berry MW: Gene clustering by latent
semantic indexing of MEDLINE abstracts. Bioinformatics 2005, 21:104-115.
15. Khatri P, Done B, Rao A, Done A, Draghici S: A semantic analysis of the
annotations of the human genome. Bioinformatics 2005, 21(16):3416-3421.
16. Eijk van der CC, van Mulligen EM, Kors JA, Mons B, Berg van den J:
Constructing an associative concept space for literature-based discovery.
Journal of the American Society for Information Science and Technology 2004,
55(5):436-444.
17. Stapley BJ, Benoit G: Biobibliometrics: information retrieval and
visualization from co-occurrences of gene names in Medline abstracts.
Proceedings of the Pacific Symposium on Biocomputing 2000, 529-540.
18. Cohen AM, Hersh WR, Dubay C, Spackman K: Using co-occurrence
network structure to extract synonymous gene and protein names from
MEDLINE abstracts. BMC Bioinformatics 2005, 6:103-103.
19. Alako BT, Veldhoven A, van Baal S, Jelier R, Verhoeven S, Rullmann T,
Polman J, Jenster G: CoPub Mapper: mining MEDLINE based on search
term co-publication. BMC Bioinformatics 2005, 6:51-51.
20. Li M, Vitányi P: An introduction to Kolmogorov complexity and its applications
New York: Springer-Verlag, 2 1997.
21. Bennett C, Gacs P, Li M, Vitányi M, Zurek W: Information distance. IEEE
Transactions on Information Theory 1998, 44(4):1407-1423.
22. Li M, Badger JH, Chen X, Kwong S, Kearney P, Zhang H: An information-
based sequence distance and its application to whole mitochondrial
genome phylogeny. Bioinformatics 2001, 17(2):149-154.
23. Cilibrasi R, Vitányi P, Wolf RD: Algorithmic Clustering of Music Based on
String Compression. Computer Music Journal 2004, 28(4):49-67.
24. Cilibrasi R, Vitányi P: Clustering by compression. IEEE Transactions on
Information Theory 2005, 51(4):1523-1545.
25. Li M, Chen X, Li X, Ma B, Vitányi P: The similarity metric. IEEE Transactions
on Information Theory 2004, 50(12):3250-3264.
26. Keogh E, Lonardi S, Ratanamahatana CA: Towards parameter-free data
mining. Proceedings of the tenth ACM SIGKDD International Conference on
Knowledge Discovery and Data mining New York, NY, USA: ACM 2004,
206-215.
27. Cilibrasi RL, Vitányi PM: The Google Similarity Distance. IEEE Transactions
on Knowledge and Data Engineering 2007, 19(3):370-383.
28. Liu H, Hu ZZ, Zhang J, Wu C: BioThesaurus: a web-based thesaurus of
protein and gene names. Bioinformatics 2006, 22:103-105.
29. Bodenreider O: The Unified Medical Language System (UMLS):
integrating biomedical terminology. Nucleic Acids Research 2004, 32
Database: 267-270.
30. Saltz J, Oster S, Hastings S, Langella S, Kurc T, Sanchez W, Kher M,
Manisundaram A, Shanbhag K, Covitz P: caGrid: design and
implementation of the core architecture of the cancer biomedical
informatics grid. Bioinformatics 2006, 22(15):1910-1916.
31. Covitz PA, Hartel F, Schaefer C, Coronado SD, Fragoso G, Sahni H,
Gustafson S, Buetow KH: caCORE: a common infrastructure for cancer
informatics. Bioinformatics 2003, 19(18):2404-2412.
32. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N,
Schwikowski B, Ideker T: Cytoscape: a software environment for
integrated models of biomolecular interaction networks. Genome
Research 2003, 13(11):2498-2504.
33. Doms A, Schroeder M: GoPubMed: exploring PubMed with the Gene
Ontology. Nucleic Acids Research 2005, , 33 Web Server: 783-786.
34. Tsuruoka Y, Tsujii J, Ananiadou S: FACTA: a text search engine for finding
associated biomedical concepts. Bioinformatics 2008, 24(21):2559-2560.
35. Brusniak MY, Bodenmiller B, Campbell D, Cooke K, Eddes J, Garbutt A,
Lau H, Letarte S, Mueller L, Sharma V, Vitek O, Zhang N, Aebersold R,
Watts J: Corra: Computational framework and tools for LC-MS discovery
Handcock et al. BMC Medical Genomics 2010, 3:7
http://www.biomedcentral.com/1755-8794/3/7
Page 8 of 9and targeted mass spectrometry-based proteomics. BMC Bioinformatics
2008, 9:542.
36. Boyle J, Rovira H, Cavnor C, Burdick D, Killcoyne S, Shmulevich I: Adaptable
data management for systems biology investigations. BMC Bioinformatics
2009, 10:79.
Pre-publication history
The pre-publication history for this paper can be accessed here: http://www.
biomedcentral.com/1755-8794/3/7/prepub
doi:10.1186/1755-8794-3-7
Cite this article as: Handcock et al.: mspecLINE: bridging knowledge of
human disease with the proteome. BMC Medical Genomics 2010 3:7.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Handcock et al. BMC Medical Genomics 2010, 3:7
http://www.biomedcentral.com/1755-8794/3/7
Page 9 of 9